| Company Name: | Varian Medical Systems, Inc. | | Ticker Symbol: | VAR | | | WWW Address: | www.varian.com | | CEO: | Timothy E. Guertin | | No. of Employees: | 4,900 | | Common Issue Type: | CS | | Business Description: | The Company designs, manufactures, sells and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 47.39 |  0.63 | 45.48 | 48.29 | 46.67 | 47.47 | 46.42 | 927719 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 5,947.4 | 125.5 | 0.76 | 2.55 | 0.00 | 18.6 | 0.0 | 47.47 - 27.10 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 47.39 | $ | | PE Ratio - LTM | 18.6 | |
| Market Capitalisation | 5,948.9 | mil |
| Latest Shares Outstanding | 125.5 | mil |
| Earnings pS (EPS) | 2.55 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 0 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 125.0 | mil |
| Float as % of Shares Outstanding | 99.5 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 15.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 6.90 | % |
| Gross Profit Margin | 45.9 | % |
| EBITDA Margin | 23.7 | % |
| Pre-Tax Profit Margin | 21.9 | % |
| Assets Turnover | 1.1 | % |
| Return on Assets (ROA) | 14.1 | % |
| Return on Equity (ROE) | 24.4 | % |
| Return on Capital Invested (ROCI) | 24.0 | % |
| Current Ratio | 2.0 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 113.5 | |
| Total Debt/Equity (Gearing Ratio) | 0.03 | |
| LT Debt/Total Capital | 2.0 | % |
| Working Capital pS | 5.86 | $ |
| Cash pS | 3.76 | $ |
| Book-Value pS | 9.79 | $ |
| Tangible Book-Value pS | 8.14 | $ |
| Cash Flow pS | 2.73 | $ |
| Free Cash Flow pS | 1.57 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.84 | |
| Price/Tangible Book Ratio | 5.82 | |
| Price/Cash Flow | 17.4 | |
| Price/Free Cash Flow | 30.2 | |
| P/E as % of Industry Group | 64.0 | % |
| P/E as % of Sector Segment | 9.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.9 | 103 | 7,249 | 17,313 |
| 4 Weeks | 47.47 | 42.15 | 40.98 | 15.6 | 108 | 9,004 | 153,075 |
| 13 Weeks | 47.47 | 38.71 | 40.83 | 16.1 | 108 | 11,585 | 706,700 |
| 26 Weeks | 47.47 | 31.21 | 35.76 | 32.5 | 110 | 14,963 | 1,870,350 |
| 52 Weeks | 47.47 | 27.10 | 40.36 | 17.4 | 95 | 17,153 | 4,271,187 |
| YTD | 47.47 | 27.10 | - | 35.2 | 110 | 17,289 | 3,924,631 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 46.38 | 46.04 | 42.67 | 38.71 | 36.83 | 0.76 | 0.63 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 12.86 | 99.3 | 11.98 |
| Income | 15.35 | 96.1 | 12.84 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 24.51 | NA | 24.87 |
| R&D | 16.63 | NA | 15.05 |
| Normalized Inc. | 15.55 | NA | 12.90 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 7.0 | 12.5 | 16.5 |
| Earnings % | 14.1 | 23.7 | 14.1 |
| EPS % | 16.4 | 26.2 | 16.4 |
| EPS $ | 0.36 | 0.16 | 0.36 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 35.96 |
| Current Ratio | 2.0 |
| Quick Ratio (Acid Test) | 1.3 |
| Liquidity Ratio (Cash) | 0.66 |
| Receivables Turnover | 4.1 |
| Average Collection Period | 88 |
| Working Capital/Equity | 63.3 |
| Working Capital pS | 6.61 |
| Cash-Flow pS | 0.00 |
| Free Cash-Flow pS | 0.00 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.69 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.2 |
| Total Debt/Equity (Gearing Ratio) | 0.03 |
| LT Debt/Equity | 0.02 |
| LT Debt/Capital Invested | 11.5 |
| LT Debt/Total Liabilities | 2.3 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.44 |
| Tobin's Q Ratio | 2.58 |
| Current P/E Ratio - LTM | 18.60 |
| Enterprise Value (EV)/EBITDA | 13.48 |
| Enterprise Value (EV)/Free Cash Flow | 0.00 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 5.82 |
| Price/Book Ratio - LTM | 4.84 |
| Price/Cash Flow Ratio | 17.4 |
| Price/Free Cash Flow Ratio - LTM | 30.2 |
| Price/Sales Ratio | 2.69 |
| P/E Ratio (1 month ago) - LTM | 16.3 |
| P/E Ratio (26 weeks ago) - LTM | 15.7 |
| P/E Ratio (52 weeks ago) - LTM | 18.4 |
| 5-Y High P/E Ratio | 34.1 |
| 5-Y Low P/E Ratio | 10.6 |
| 5-Y Average P/E Ratio | 24.3 |
| Current P/E Ratio as % of 5-Y Average P/E | 77 |
| P/E as % of Industry Group | 64.0 |
| P/E as % of Sector Segment | 9.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 18.2 |
| PER SHARE FIGURES |
| LT Debt pS | 0.19 |
| Current Liabilities pS | 6.71 |
| Tangible Book Value pS - LTM | 8.14 |
| Book Value pS - LTM | 9.79 |
| Capital Invested pS | 10.64 |
| Cash pS - LTM | 3.76 |
| Cash Flow pS - LTM | 2.73 |
| Free Cash Flow pS - LTM | 1.57 |
| Earnings pS (EPS) | 2.55 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.00 |
| Free Cash Flow Margin 5YEAR AVG | 9.69 |
| Net Profit Margin | 14.4 |
| Net Profit Margin - 5YEAR AVRG. | 14.3 |
| Equity Productivity | 1.69 |
| Return on Equity (ROE) | 24.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 29.0 |
| Capital Invested Productivity | 1.66 |
| Return on Capital Invested (ROCI) | 23.9 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 27.4 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | 13.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | 14.9 |
| Gross Profit Margin | 45.9 |
| Gross Profit Margin - 5YEAR AVRG. | 43.9 |
| EBITDA Margin - LTM | 23.7 |
| EBIT Margin - LTM | 22.1 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 20.5 |
| Effective Tax Rate | 30.2 |
| Effective Tax Rate - 5YEAR AVRG. | 29.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 94 |
| Revenue per Employee | 0 |
| Net Income per Employee | 0 |
| Average Collection Period | 94 |
| Receivables Turnover | 4.1 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 14.5 |
| Accounts Payble/Sales | 5.24 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | 2.67 |
| Fixed Assets Turnover | 3.48 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 4.00 |
| Revenue per $ Plant | 8.38 |
| Revenue per $ Common Equity | 1.69 |
| Revenue per $ Capital Invested | 1.66 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 15.5 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |